Literature DB >> 21975578

Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient.

Rodolfo Sacco, Irene Bargellini, Barbara Ginanni, Marco Bertini, Elena Bozzi, Emanuele Altomare, Valentina Battaglia, Antonio Romano, Emanuele Tumino, Matteo Di Biase, Giampaolo Bresci, Carlo Bartolozzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21975578     DOI： 10.1007/s12029-011-9328-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  14 in total

1.  Sorafenib in advanced clear-cell renal-cell carcinoma.

Authors:  Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

Review 2.  Vascular endothelial growth factor polymorphisms: role in response and toxicity of tyrosine kinase inhibitors.

Authors:  Susan A J Vaziri; Jenny Kim; Mahrukh K Ganapathi; Ram Ganapathi
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

3.  Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

Authors:  Ghassan K Abou-Alfa; Philip Johnson; Jennifer J Knox; Marinela Capanu; Irina Davidenko; Juan Lacava; Thomas Leung; Bolorsukh Gansukh; Leonard B Saltz
Journal:  JAMA       Date:  2010-11-17       Impact factor: 56.272

Review 4.  Sorafenib therapy for metastatic renal carcinoma in patients with low cardiac ejection fraction: report of two cases and literature review.

Authors:  Pratima Kamada; Arkadiusz Z Dudek
Journal:  Cancer Invest       Date:  2010-06       Impact factor: 2.176

5.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

Review 6.  Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.

Authors:  Michael K K Wong; Anthony Jarkowski
Journal:  Pharmacotherapy       Date:  2009-04       Impact factor: 4.705

Review 7.  Cardiotoxicity induced by tyrosine kinase inhibitors.

Authors:  George S Orphanos; George N Ioannidis; Alexandros G Ardavanis
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

Review 8.  An overview of small-molecule inhibitors of VEGFR signaling.

Authors:  S Percy Ivy; Jeannette Y Wick; Bennett M Kaufman
Journal:  Nat Rev Clin Oncol       Date:  2009-09-08       Impact factor: 66.675

9.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

10.  Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report.

Authors:  Chiara Valsuani; Olimpia Siclari; Andrea Camerini; Maria Laura Canale; Marianna Rondini; Sara Donati; Paolo Puccinelli; Gianna Tartarelli; Cheti Puccetti; Domenico Amoroso
Journal:  Cases J       Date:  2009-12-02
View more
  1 in total

1.  Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma.

Authors:  Rodolfo Sacco; Lorenzo Faggioni; Irene Bargellini; Antonio Romano; Marco Bertini; Barbara Ginanni; Valentina Battaglia; Michele Bertoni; Elena Bozzi; Graziana Federici; Salvatore Metrangolo; Giuseppe Parisi; Emanuele Neri; Elisabetta Sodini; Emanuele Tumino; Giampaolo Bresci; Carlo Bartolozzi
Journal:  J Gastrointest Cancer       Date:  2012-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.